July 1 - September 30, 2021
Who is ready for a challenge?
Warmer weather is here, and our world is opening up, again, which has all of us at PSC Partners excited! We hope you’ll join the PSC Partners staff and board of directors on our mission to raise PSC awareness and funds by walking 83.01 miles (133.5 km) between July 1-September 30, 2021.
Why did we choose 83.01 as a goal? Because the unique disease code for primary sclerosing cholangitis (PSC) is K83.01. (Get more information about the PSC ICD-10-CM code here.)
For this fundraising event, walk as an individual or gather a team, wear PSC Partners gear (Link to Shop Here), and raise funds for PSC research! Donations can be made per mile/km or given in one lump sum. $83.01 is the suggested donation, but feel free to raise more or donate whatever amount feels comfortable to you.
If you don’t want to walk, or are unable to, you can complete the event in a different way.
You may choose to:
- Or choose another form of exercise
If movement is difficult, how about:
- Performing 83 random acts of kindness
- Writing 83 postcards to family & friends
- Crafting 83 friendship bracelets with your kids
- Reaching out to 83 people in the PSC community
- Asking someone (or a team of friends/family) to complete the 83.01 on your behalf
Be creative and complete this unique fundraiser in a way that is fun and doable for you!
Watch our newsletter (Sign Up Here) and social media pages for updates.
If you are unable to participate but would still like to financially support the WALK83.01 effort, click the button below. Thank you!
HELP US RAISE AWARENESS!
Visit the PSC Partners Online Shop HERE -- Wear PSC Partners gear! In addition to our usual branded clothing, we have created a special WALK83.01 shirt.
Download Printable Mascot Here (Horizontal) -- Bili is the Mascot of WALK83.01. Take Bili on this adventure with you, and post selfies. Use #PSCWALK8301 and #PSCPartners. Download the Vertical Mascot Version Here.
Complete your profile and join PSC Partners Seeking a Cure in advancing PSC research towards a cure.